Overview of early and investigational chemotherapeutic agents in solid tumors.
A tentative evaluation is proposed for the clinical status of 15 early and investigational drugs in human solid tumors.
D000477:Alkylating Agents / Q000627:therapeutic use*; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001388:Aziridines / Q000627:therapeutic use; D001391:Azo Compounds / Q000627:therapeutic use; D002166:Camptothecin / Q000627:therapeutic use; D003515:Cycloleucine / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D005467:Floxuridine / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D010848:Picolinic Acids / Q000627:therapeutic use; D010984:Platinum / Q000627:therapeutic use; D011160:Porfiromycin / Q000627:therapeutic use; D013308:Streptonigrin / Q000627:therapeutic use; D013713:Teniposide / Q000627:therapeutic use; D013852:Thiotepa / Q000627:therapeutic use; D014372:Tubercidin / Q000627:therapeutic use
D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D001388:Aziridines; D001391:Azo Compounds; D009588:Nitrogen Mustard Compounds; D010848:Picolinic Acids; D005467:Floxuridine; D003515:Cycloleucine; D013308:Streptonigrin; D010984:Platinum; D005047:Etoposide; D013852:Thiotepa; D013713:Teniposide; D011160:Porfiromycin; D014372:Tubercidin; D002166:Camptothecin